Sort
17,828 grants matching “crispr”
Project 2: Regulation of Rotavirus Host Range, Neutralization, and M cell Interactions in Enteric Biomimetics
$262,950Harry Bernard Greenberg · Stanford University · U19 · FY2024 · AI
CANCAN - SALK
$262,948Janelle S Ayres · Salk Institute For Biological Studies · OT2 · FY2022 · CA
Exploiting Therapeutic Vulnerabilities
$262,672William A Weiss · Children'S Hospital Of Los Angeles · P01 · FY2019 · CA
Phenotypic Assay Design and Development for Rare and Neglected Diseases
$262,502James Inglese · National Center For Advancing Translational Sciences · ZIA · FY2016 · TR
Rapid In Vivo Modeling of Developmental Disorders
$262,500Stephen A Murray · Jackson Laboratory · R21 · FY2018 · OD
Epigenetic Silencing of HSA21 in Down Syndrome
$262,500Volney L Sheen · Beth Israel Deaconess Medical Center · R21 · FY2020 · NS
CRISPR/Cas9 Gene Editing to Rescue Vision in Rodent Model for Autosomal Dominant Retinitis Pigmentosa
$262,500Shaomei Wang · Cedars-Sinai Medical Center · R21 · FY2017 · EY
14 Functional Genomics Core
$262,490Dihua Yu · University Of Tx Md Anderson Can Ctr · P30 · FY2025 · CA
Unraveling the function of CD276
$262,257Bradley D St Croix · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Connecting the gap between GWAS and functional targets for lupus susceptibility
$262,200Swapan K Nath · Oklahoma Medical Research Foundation · R21 · FY2022 · AI
Kinase-independent mechanism of resistance to FLT3 inhibitors in AML
$262,179Laquita M Jones · Cincinnati Childrens Hosp Med Ctr · K08 · FY2025 · CA
Kinase-independent mechanism of resistance to FLT3 inhibitors in AML
$262,179Laquita M Jones · Cincinnati Childrens Hosp Med Ctr · K08 · FY2023 · CA
Kinase-independent mechanism of resistance to FLT3 inhibitors in AML
$262,179Laquita M Jones · Cincinnati Childrens Hosp Med Ctr · K08 · FY2024 · CA
Project 2: Next Generation TOP1 Inhibition for the Treatment of Ovarian Cancer
$262,127Scott H Kaufmann · Mayo Clinic Rochester · P50 · FY2021 · CA
Defining the role of KEAP/NRF2 signaling dysregulation and sensory nerve reprograming during acquisition of cisplatin resistance and metastasis in HNSCC
$262,103Abdullah Ali Osman · University Of Tx Md Anderson Can Ctr · U54 · FY2024 · CA
Exploiting the Metabolic Dependencies of Pediatric AML
$262,053Alexandra Stevens · Baylor College Of Medicine · K08 · FY2023 · CA
Exploiting the Metabolic Dependencies of Pediatric AML
$262,053Alexandra Stevens · Baylor College Of Medicine · K08 · FY2024 · CA
Exploiting the Metabolic Dependencies of Pediatric AML
$262,053Alexandra Stevens · Baylor College Of Medicine · K08 · FY2025 · CA
Identification of Mycobacterium tuberculosis-derived metabolites acting as ligands for MR1-restricted T cells.
$262,000Charles Kyriakos Vorkas · State University New York Stony Brook · R21 · FY2023 · AI
Genomics
$261,805Peter D. Adams · Sanford Burnham Prebys Medical Discovery Institute · P30 · FY2024 · CA
Project 2: Next Generation TOP1 Inhibition for the Treatment of Ovarian Cancer
$261,552Scott H Kaufmann · Mayo Clinic Rochester · P50 · FY2022 · CA
DNA Elements Underlying Celiac and Crohn's Susceptibility
$261,525Benjamin Tycko · Hackensack University Medical Center · R21 · FY2018 · AI
Amphetamine in adolescence disrupts frontal cortex development
$261,477Cecilia Flores · Mcgill University · R01 · FY2021 · DA
Role for Circular RNAs in Compulsive Cocaine Intake
$261,030Paul J Kenny · Icahn School Of Medicine At Mount Sinai · P01 · FY2019 · DA
P3: Molecular Mechanisms Underlying Therapy Response to Radiation and Immune Checkpoint BlockadeýSUBAWARD
$260,919David Sung-Wen Yu · Cleveland Clinic Lerner Com-Cwru · U54 · FY2024 · CA